Showing 17,641 - 17,660 results of 29,775 for search '(( 5 step decrease ) OR ( 50 ((((ms decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.12s Refine Results
  1. 17641
  2. 17642
  3. 17643
  4. 17644
  5. 17645

    Metformin does not further increase the median lifespan of DR-constitutive mutant eat-2, and metformin treatment triggers several DR phenotypes in wild-type <i>C. elegans</i> witho... by Brian Onken (86790)

    Published 2010
    “…<p><b>A.</b> Survival curves of <i>eat-2(ad1116)</i> mutants raised on 0 mM, 1 mM, 10 mM, and 50 mM metformin plates at 20°C. …”
  6. 17646

    Regulation of MCF-7 mammosphere formation by breast cancer promoters and metformin. by Ji-Won Jung (194917)

    Published 2011
    “…On the other hand, metformin treatment decreased MCF-7 proliferation (mean ± SD, n = 3). *, <i>P</i><0.05; **, <i>P</i><0.01; ***, <i>P</i><0.001. …”
  7. 17647
  8. 17648

    Variation of average codeword length (ACL) by number of edges. by Dario Elias (8882177)

    Published 2020
    “…A positive variation indicates a decrease in the ACL. …”
  9. 17649

    Complementary conditioning measures across the clinical study groups. by Gabriela Ribeiro (4748373)

    Published 2024
    “…CS<sup>+</sup> (F<sub>(1, 50)</sub> = 5.2, <i>P</i> = 0.03), with a no significant effects for Group (F<sub>(2, 50)</sub> = 0.1, <i>P</i> = 0.9) nor for interaction (F<sub>(2, 50)</sub> = 0.9, <i>P</i> = 0.4). …”
  10. 17650

    Genome-wide genic copy numbers for nine Macaca species based on 1kb windows by Jing Li (7426562)

    Published 2019
    “…<div><br></div><div>Methods: </div><div><p>We employed FastQC (v0.11.8) (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) to do quality control checks on raw data of resequencing genomes, then used Trimmomatic (v0.36) (Bolger et al. 2014) to filter and trim the reads. …”
  11. 17651
  12. 17652
  13. 17653

    Histone deacetylase (HDAC) inhibitor assessment. by Ilona Tkachyova (343715)

    Published 2016
    “…ITF 2357, an HDAC inhibitor which is structurally and functionally similar to SAHA, produced a dose-response curve with IC<sub>50</sub> of 0.2 μM. …”
  14. 17654

    Plk1 inhibition suppresses the clonogenic potential of SUM149 and SUM159. by Antonio Giordano (55096)

    Published 2019
    “…(B) EC<sub>50</sub> was defined as 50% colony inhibition. Single agents EC<sub>50</sub> were reported for each TNBC cell line and drug. …”
  15. 17655

    Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  16. 17656

    Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  17. 17657

    Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  18. 17658

    Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  19. 17659

    Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  20. 17660

    Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”